[HTML][HTML] Clinical results of surgery for retroperitoneal sarcoma with major blood vessel involvement
…, C Leowardi, D Böckler, G Mechtersheimer… - Journal of vascular …, 2006 - Elsevier
PURPOSE: The study was conducted to evaluate the clinical results of resection for
retroperitoneal soft tissue sarcoma (STS) with vascular involvement. METHODS: The study …
retroperitoneal soft tissue sarcoma (STS) with vascular involvement. METHODS: The study …
Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells.
F Leithäuser, J Dhein, G Mechtersheimer… - … ; a journal of technical …, 1993 - europepmc.org
Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor
necrosis factor receptor superfamily, in normal and neoplastic cells. - Abstract - Europe PMC …
necrosis factor receptor superfamily, in normal and neoplastic cells. - Abstract - Europe PMC …
[HTML][HTML] Sarcoma classification by DNA methylation profiling
…, U Flucke, I Petersen, G Mechtersheimer… - Nature …, 2021 - nature.com
Sarcomas are malignant soft tissue and bone tumours affecting adults, adolescents and
children. They represent a morphologically heterogeneous class of tumours and some …
children. They represent a morphologically heterogeneous class of tumours and some …
Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody
…, G Schindler, S Pusch, G Mechtersheimer… - Acta …, 2011 - Springer
Activating mutations of the serine threonine kinase v-RAF murine sarcoma viral oncogene
homolog B1 (BRAF) are frequent in benign and malignant human tumors and are emerging …
homolog B1 (BRAF) are frequent in benign and malignant human tumors and are emerging …
TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma
…, S Hartmann, G Mechtersheimer… - Journal of Experimental …, 2009 - rupress.org
Proliferation and survival of Hodgkin and Reed/Sternberg (HRS) cells, the malignant cells of
classical Hodgkin lymphoma (cHL), are dependent on constitutive activation of nuclear …
classical Hodgkin lymphoma (cHL), are dependent on constitutive activation of nuclear …
Meningeal hemangiopericytoma and solitary fibrous tumors carry the NAB2-STAT6 fusion and can be diagnosed by nuclear expression of STAT6 protein
…, M Simon, C Herold-Mende, G Mechtersheimer… - Acta …, 2013 - Springer
Non-central nervous system hemangiopericytoma (HPC) and solitary fibrous tumor (SFT)
are considered by pathologists as two variants of a single tumor entity now subsumed under …
are considered by pathologists as two variants of a single tumor entity now subsumed under …
Classical Hodgkin lymphoma is characterized by recurrent copy number gains of the short arm of chromosome 2
…, S Gesk, S Ohl, G Mechtersheimer… - Blood, The Journal …, 2002 - ashpublications.org
Hodgkin-and Reed-Sternberg (HRS) cells microdissected from 41 classical Hodgkin
lymphomas (cHL) of 40 patients comprising 8 lymphocyte-rich (cHL-LR), 16 nodular …
lymphomas (cHL) of 40 patients comprising 8 lymphocyte-rich (cHL-LR), 16 nodular …
Genomic Imbalances Including Amplification of the Tyrosine Kinase Gene JAK2 in CD30+ Hodgkin Cells
…, M Küpper, S Ohl, F Von Bonin, G Mechtersheimer… - Cancer research, 2000 - AACR
Comparative genomic hybridization was applied for a comprehensive screening of
frequently occurring net gains and losses of chromosomal subregions in small populations …
frequently occurring net gains and losses of chromosomal subregions in small populations …
[HTML][HTML] Integrative genomic and transcriptomic analysis of leiomyosarcoma
…, S Schimmack, A Ulrich, G Mechtersheimer… - Nature …, 2018 - nature.com
Leiomyosarcoma (LMS) is an aggressive mesenchymal malignancy with few therapeutic
options. The mechanisms underlying LMS development, including clinically actionable …
options. The mechanisms underlying LMS development, including clinically actionable …
BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis
…, L Müllauer, G Mechtersheimer… - Blood, The Journal …, 2012 - ashpublications.org
Langerhans cell histiocytosis (LCH) is a clinically and histologically heterogeneous disorder.
Its classification as either reactive inflammatory or neoplastic has been a matter of debate …
Its classification as either reactive inflammatory or neoplastic has been a matter of debate …